LIMITLESS Physician Compensation
Webinar: LIMITLESS Physician Compensation (12/6/23 11am MT) Together, the Stark Law exception for in-office ancillary service referrals (§411.355(b)) AND the special group practice rules for overall profit shares (§411.352(i)) allow for LIMITLESS physician income from in-office ancillary services. This phenomenon is completely separate from the Fair Market Value requirements for most other forms of physician […]
Ophthalmology Physician Practice Management Fees
Ophthalmology Physician Practice Management Fees Ophthalmology physician practices cannot be owned by for-profit corporation in states like California, New York, and Texas that prohibit the Corporate Practice of Medicine. Management arrangements are used by private equity firms, platform physician practice companies, publicly-traded practice operators, and other for-profit businesses to manage the non-medical staff, facilities, equipment, supplies, and […]
Dermatology Physician Practice Management Fees
Dermatology: Physician Practice Management Fees Dermatology physician practices cannot be owned directly by non-physicians in states that ban the Corporate Practice of Medicine like California, New York, and Texas. Physician practice management arrangements are used by private equity firms, platform physician practice companies, publicly-traded practice operators, and other for-profit businesses to manage the non-medical staff, facilities, […]
Orthopaedic Surgery Physician Practice Management Fees
Orthopaedic Surgery: Physician Practice Management Fees Physician practice management arrangements are used by private equity firms, platform physician practice companies, and publicly-traded practice operators. These arrangements enable for-profit businesses to own and manage facilities, equipment, supplies, business services, and non-medical staff in states that ban the Corporate Practice of Medicine like California, New York, and […]
Fairness Opinions or Valuations Required for Adviser-Led Secondary Transactions
Fairness Opinions or Valuations Required for Adviser-Led Secondary Transactions During March of 2022, the U.S. Securities and Exchange Commission published a rule (IA-5955) proposing to require Fairness Opinions or Valuations for Adviser-Led Secondary Transactions. The SEC solicited comments from industry participants as to whether it should require Fairness Opinions or Valuation Opinions for Adviser-Led Secondary […]